Extensive atypical genital herpes simplex type 2 infection as an initial manifestation of acquired immune deficiency syndrome

Acta Dermatovenerologica Croatica

Volumn 16, Issue 3, 2008, Pages 145-148

  Rigopoulos, Dimitris ^a   Malouchou, Katerina ^a   Alevizos, Alevizos ^b   Larios, George ^a,c   Papadogiorgaki, Heleni ^c   Lima, Katerina ^c   Antoniou, Christina ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b Health Center of Vyronas   (Greece)

^c ANDREAS SYGROS HOSPITAL   (Greece)

Author keywords

Acquired immune deficiency syndrome (AIDS); Herpes simplex virus type 2 (HSV 2); Human immunodeficiency virus (HIV); Oral candidiasis

Indexed keywords

ACICLOVIR; FLUCONAZOLE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CASE REPORT; CELLULAR IMMUNITY; CLINICAL FEATURE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENITAL HERPES; GENITAL ULCER; HERPES SIMPLEX VIRUS 2; HERPES VIRUS INFECTION; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNE DEFICIENCY; MALE; THRUSH; WESTERN BLOTTING;

ACYCLOVIR; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIVIRAL AGENTS; BLOTTING, WESTERN; DIAGNOSIS, DIFFERENTIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HERPES GENITALIS; HERPESVIRUS 2, HUMAN; HUMANS;

EID: 51949086113     PISSN: 1330027X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Simonsen M, Nahas SC, da Silva Filho EV, Araújo SE, Kiss DR, Nahas CS. Atypical perianal herpes simplex infection in HIV-positive patients. Clinics 2008;63:143-6.
2. Malkin JE. Epidemiology of genital herpes simplex virus infection in developed countries. Herpes 2004;11(Suppl 1):2A-23A.
3. Cowan FM, Johnson AM, Ashley RL, Corey L, Mindel A. Antibody to HSV-2 as a serological marker of sexual lifestyle in populations. BMJ 1994;309:1325-9.
4. Panasiti V, Devirgiliis V, Borroni RG, Spataro A, Melis L, Petrella MC, Pala S. Atypical cutaneous manifestation of HSV-2 with Candida albicans co-infection in a patient with HIV-1. J Infect 2007;54:e55-7. Epub 2006 May 22.
5. Siegal FP, Lopez C, Hammer GS, et al. Severe acquired immunodeficiency in male homosexuals, manifested by chronic perianal ulcerative herpes simplex lesions. N Engl J Med 1981;305:1439-44.
6. McGrath BJ, Newman CL. Genital herpes simplex infections in patients with the acquired immunodeficiency syndrome. Pharmacotherapy 1994;14:529-42.
7. Corey L, Wald A, Celum CL, Quinn TC. The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemics. J Acquir Immune Defic Syndr 2004;35:435-45.
8. Schacker T, Zeh J, Hu H, Hill E, Corey L. Frequency of symptomatic and asymptomatic herpes simplex virus type 2 reactivations among human immunodeficiency virus-infected men. J Infect Dis 1998;178:1616-22.
9. Serwadda D, Gray R, Sewankambo N, Wabwire-Mangen F, Chen M, Quinn T, et al. Human immunodeficiency virus acquisition associated with genital ulcer disease and herpes simplex virus type 2 infection: a nested case control study in Rakai, Uganda. J Infect Dis 2003;188:1492-7.
10. Gwanzura L, McFarland W, Alexander D, Burke RL, Katzenstein D. Association between human immunodeficiency virus and herpes simplex virus type 2 seropositivity among male factory workers in Zimbabwe. J Infect Dis 1998;177:481-4.
11. Chen C, Ballard R, Beck-Sague C, Dangor Y, Radebe F, Schmid S, et al. Human immunodeficiency virus infection and genital ulcer disease in South Africa. Sex Transm Dis 2000;27:21-8.
12. Suligoi B, Dorrucci M, Volpi A, Andreoni M, Zerboni R, Rezza G, and the Italian Seroconversion Study Group. Prevalence and determinants of herpes simplex virus type 2 infection in a cohort of HIV-positive individuals in Italy. Sex Transm Dis 2002;29:665-7.
13. Andreoletti L, Piendoir E, Legoff J, Brodard V, Beguinot I, Strady C, et al. High seroprevalence of herpes simplex virus type 2 infection in French human immunodeficiency virus type 1-infected outpatients. J Clin Microbiol 2005;43:4215-7.
14. Ramaswamy M, Sabin C, McDonald C, Smith M, Taylor C, Geretti AM. Herpes simplex virus type 2 (HSV-2) seroprevalence at the time of HIV-1 diagnosis and seroincidence after HIV-1 diagnosis in an ethnically diverse cohort of HIV-1 infected persons. Sex Transm Dis 2006;33:96-101.
15. Wald A, Link K. Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis. J Infect Dis 2002;185:45-52.